{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:38Z","timestamp":1790838578667,"version":"4.1.0"},"reference-count":102,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01292","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T03:35:49Z","timestamp":1508124949000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Defective Suppressor of Cytokine Signaling 1 Signaling Contributes to the Pathogenesis of Systemic Lupus Erythematosus"],"prefix":"10.3389","volume":"8","author":[{"given":"Huixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5694\/mja16.01229","article-title":"Systemic lupus erythematosus: an update","volume":"206","author":"Golder","year":"2017","journal-title":"Med J Aust"},{"key":"B2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fimmu.2015.00550","article-title":"Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus","volume":"6","author":"Gottschalk","year":"2015","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fimmu.2016.00035","article-title":"Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE","volume":"7","author":"Mahajan","year":"2016","journal-title":"Front Immunol"},{"key":"B5","first-page":"236","article-title":"Haematological abnormalities in systemic lupus erythematosus","volume":"39","author":"Aleem","year":"2014","journal-title":"Acta Reumatol Port"},{"key":"B6","doi-asserted-by":"publisher","first-page":"347141","DOI":"10.1155\/2012\/347141","article-title":"Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE","volume":"2012","author":"Su","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1042\/BST20130077","article-title":"Regulation of Janus kinases by SOCS proteins","volume":"41","author":"Kershaw","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"B8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.immuni.2012.01.010","article-title":"JAK\u2019s SOCS: a mechanism of inhibition","volume":"36","author":"Yoshimura","year":"2012","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/ni1012","article-title":"Suppressors of cytokine signaling and immunity","volume":"4","author":"Kubo","year":"2003","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/eji.201344369","article-title":"SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications","volume":"44","author":"Liang","year":"2014","journal-title":"Eur J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10238-014-0309-2","article-title":"Decreased SOCS1 mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus in a Chinese population","volume":"15","author":"Qiu","year":"2015","journal-title":"Clin Exp Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/sji.12475","article-title":"Therapeutic potential for targeting the suppressor of cytokine signalling-1 pathway for the treatment of SLE","volume":"84","author":"Sukka-Ganesh","year":"2016","journal-title":"Scand J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e000104","DOI":"10.1136\/lupus-2015-000104","article-title":"Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study","volume":"2","author":"Urowitz","year":"2015","journal-title":"Lupus Sci Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/emboj\/18.5.1309","article-title":"The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop","volume":"18","author":"Yasukawa","year":"1999","journal-title":"EMBO J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s000180050392","article-title":"The Janus kinase family of protein tyrosine kinases and their role in signaling","volume":"55","author":"Yeh","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fimmu.2015.00183","article-title":"SOCS1 mimetics and antagonists: a complementary approach to positive and negative regulation of immune function","volume":"6","author":"Ahmed","year":"2015","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.immuni.2011.12.015","article-title":"Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity","volume":"36","author":"Babon","year":"2012","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1006\/cyto.2000.0718","article-title":"IL-5-induced JAB-JAK2 interaction","volume":"12","author":"Zahn","year":"2000","journal-title":"Cytokine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1074-7613(03)00240-1","article-title":"Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity","volume":"19","author":"Hanada","year":"2003","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/atvbaha.110.207464","article-title":"Suppressors of cytokine signaling (SOCS) proteins and JAK\/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3","volume":"31","author":"Tamiya","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B21","first-page":"15","article-title":"Cytokines expression in SLE nephritis","volume":"15","author":"Gigante","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/jcp.25748","article-title":"Tolerogenic probiotics: potential immunoregulators in systemic lupus erythematosus","volume":"232","author":"Esmaeili","year":"2017","journal-title":"J Cell Physiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cytogfr.2013.03.005","article-title":"Suppression of cytokine signaling: the SOCS perspective","volume":"24","author":"Linossi","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1074\/jbc.M409863200","article-title":"Role of tyrosine 441 of interferon-\u03b3 receptor subunit1 in SOCS-1-mediated attenuation of STAT1 activation","volume":"280","author":"Qing","year":"2005","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.clim.2009.06.010","article-title":"A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 mice","volume":"133","author":"Sharabi","year":"2009","journal-title":"Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/sji.12330","article-title":"Systemic lupus erythematosus-a disease with a dysregulated type I interferon system","volume":"82","author":"Hagberg","year":"2015","journal-title":"Scand J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/eji.201040649","article-title":"Interferon-\u03b1 induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB\u00d7NZW)F1 mice but not in BALB\/c mice","volume":"41","author":"Mathian","year":"2011","journal-title":"Eur J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-8411(02)00109-9","article-title":"Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice","volume":"20","author":"Braun","year":"2003","journal-title":"J Autoimmun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1084\/jem.20111644","article-title":"Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation","volume":"209","author":"Joo","year":"2012","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.intimp.2016.10.012","article-title":"The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus","volume":"40","author":"Luo","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ni1287","article-title":"Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity","volume":"7","author":"Fenner","year":"2006","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1096\/fj.05-5493fje","article-title":"IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia","volume":"20","author":"Qin","year":"2006","journal-title":"FASEB J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/intimm\/dxh030","article-title":"Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases","volume":"16","author":"Fujimoto","year":"2004","journal-title":"Int Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0092-8674(00)80048-3","article-title":"SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality","volume":"98","author":"Marine","year":"1999","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.4049\/jimmunol.165.4.1799","article-title":"Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1\/suppressors of cytokine signaling-1 transgenic mice","volume":"165","author":"Fujimoto","year":"2000","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.4049\/jimmunol.180.6.3746","article-title":"Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN on STAT3 and Smads","volume":"180","author":"Tanaka","year":"2008","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1084\/jem.20110428","article-title":"SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-gamma and IL-17A production","volume":"208","author":"Takahashi","year":"2011","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jim.2013.08.008","article-title":"In vitro Th1 and Th2 cell polarization is severely influenced by the initial ratio of na\u00efve and memory CD4+ T cells","volume":"397","author":"Blom","year":"2013","journal-title":"J Immunol Methods"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/eji.201444726","article-title":"TGF-\u03b2 converts Th1 cells into Th17 cells through stimulation of Runx1 expression","volume":"45","author":"Liu","year":"2015","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/0961203312457718","article-title":"The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis","volume":"21","author":"Chen","year":"2012","journal-title":"Lupus"},{"key":"B44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4049\/jimmunol.1600441","article-title":"SOCS1 is a key molecule that prevents regulatory T cell plasticity under inflammatory conditions","volume":"199","author":"Takahashi","year":"2017","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cei.12991","article-title":"Two separate effects contribute to regulatory T-cell defect in SLE patients and their unaffected relatives","volume":"189","author":"Costa","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B46","first-page":"171","article-title":"An update on pathogenesis of systemic lupus erythematosus","volume":"8","author":"Ahmadpoor","year":"2014","journal-title":"Iran J Kidney Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/ar4188","article-title":"CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice","volume":"15","author":"Weigert","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"943149","DOI":"10.1155\/2014\/943149","article-title":"SOCS1 and regulation of regulatory T cells plasticity","volume":"2014","author":"Takahashi","year":"2014","journal-title":"J Immunol Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.4049\/jimmunol.174.7.4325","article-title":"Induction of hyper TH1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene","volume":"174","author":"Hanada","year":"2005","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1172\/JCI26169","article-title":"SOCS1 restricts dendritic cells\u2019s ability to break self tolerance and induce antitumor immunityby regulating IL-12 production and signaling","volume":"116","author":"Evel-Kabler","year":"2006","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6269157","DOI":"10.1155\/2016\/6269157","article-title":"Breakdown of immune tolerance in systemic lupus erythematosus by dendritic cells","volume":"2016","author":"Liao","year":"2016","journal-title":"J Immunol Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.molimm.2015.11.001","article-title":"Anti-DNA antibody mediated catalysis is isotype dependent","volume":"69","author":"Xia","year":"2016","journal-title":"Mol Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3389\/fimmu.2017.00610","article-title":"Anti-dsDNA IgG participates in renal fibrosis through suppressing the SOCS1 signals","volume":"8","author":"Wang","year":"2017","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/cei.12734","article-title":"A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens","volume":"183","author":"Xia","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jaut.2012.06.005","article-title":"The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies","volume":"39","author":"Xia","year":"2012","journal-title":"J Autoimmun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrrheum.2014.33","article-title":"The BAFF\/APRIL system in SLE pathogenesis","volume":"10","author":"Vincent","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejphar.2013.05.016","article-title":"Oridonin ameliorates lupus-like symptoms of MRL(lpr\/lpr) mice by inhibition of B-cell activating factor (BAFF)","volume":"715","author":"Zhou","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1074-7613(02)00425-9","article-title":"BAFF\/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2","volume":"17","author":"Kayagaki","year":"2002","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2015.06.001","article-title":"BAFF-driven autoimmunity requires CD19 expression","volume":"62","author":"Fairfax","year":"2015","journal-title":"J Autoimmun"},{"key":"B60","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/0961203309357437","article-title":"Suppressor of cytokine signaling 1 gene expression and polymorphisms in systemic lupus erythematosus","volume":"19","author":"Chan","year":"2010","journal-title":"Lupus"},{"key":"B62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/0961203306075383","article-title":"Activation of the STAT1 signalling pathway in lupus nephritis in MRL\/lpr mice","volume":"16","author":"Dong","year":"2007","journal-title":"Lupus"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00467-009-1163-4","article-title":"Expression of JAKs\/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis","volume":"24","author":"Liang","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fmmu.2015.00475","article-title":"Mechanisms of kidney injury in lupus nephritis \u2013 the role of anti-dsDNA antibodies","volume":"6","author":"Yung","year":"2015","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s10875-012-9724-x","article-title":"The lupus-derived anti-double-stranded DNA IgG contributes to myofibroblast-like phenotype in mesangial cells","volume":"32","author":"Zhang","year":"2012","journal-title":"J Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/art.39219","article-title":"The role of microRNAs and human epidermal growth factor receptor 2 in proliferative lupus nephritis","volume":"67","author":"Costa-Reis","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12016-016-8533-z","article-title":"Molecular and immunological basis of tubulo-interstitial injury in lupus nephritis: a comprehensive review","volume":"52","author":"Yung","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/ASN.2012080849","article-title":"miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1","volume":"24","author":"Zhou","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000329325","article-title":"Suppressors of cytokine signaling inhibit tubular epithelial cell-myofibroblast transdifferentiation","volume":"34","author":"Liu","year":"2011","journal-title":"Am J Nephrol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/0961203316646861","article-title":"Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients","volume":"25","author":"Ma","year":"2016","journal-title":"Lupus"},{"key":"B71","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fimmu.2014.00357","article-title":"SOCS proteins in macrophage polarization and function","volume":"5","author":"Wilson","year":"2014","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.4049\/jimmunol.1201168","article-title":"SOCS3 deficiency promotes M1 macrophage polarization and inflammation","volume":"189","author":"Qin","year":"2012","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1189\/jlb.1110644","article-title":"Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function","volume":"90","author":"Whyte","year":"2011","journal-title":"J Leukoc Biol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1042\/CS20120198","article-title":"Inflammation and the pathogenesis of diabetic nephropathy","volume":"124","author":"Wada","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ki.2011.217","article-title":"Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis","volume":"80","author":"Anders","year":"2011","journal-title":"Kidney Int"},{"key":"B76","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MNH.0000000000000079","article-title":"JAK inhibition and progressive kidney disease","volume":"24","author":"Brosius","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B77","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1681\/ASN.2016020237","article-title":"Suppressor of cytokine signaling-1 peptidomimetic limits progression of diabetic nephropathy","volume":"28","author":"Recio","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.it.2009.07.001","article-title":"SOCS1 and SOCS3 in the control of CNS immunity","volume":"30","author":"Baker","year":"2009","journal-title":"Trends Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/eji.201343370","article-title":"Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses","volume":"43","author":"Madonna","year":"2013","journal-title":"Eur J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrrheum.2012.208","article-title":"Global trends, potential mechanisms and early detection of organ damage in SLE","volume":"9","author":"Mak","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/S1807-59322011000100014","article-title":"IL-2, IL-5, TNF-\u03b1 and IFN-\u03b3 mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions","volume":"66","author":"Carneiro","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.4049\/jimmunol.1001426","article-title":"The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Kr\u00fcppel-like factor-4, and it is dysregulated in psoriatic keratinocytes","volume":"185","author":"Madonna","year":"2010","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4049\/jimmunol.169.1.434","article-title":"Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1","volume":"169","author":"Federici","year":"2002","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaut.2016.06.013","article-title":"The diagnosis and clinical management of the neuropsychiatric manifestations of lupus","volume":"74","author":"Govoni","year":"2016","journal-title":"J Autoimmun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.clim.2015.01.010","article-title":"Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases","volume":"157","author":"Ichinose","year":"2015","journal-title":"Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2013.00484","article-title":"Neuropsychiatric lupus, the blood brain barrier, and the TWEAK\/Fn14 pathway","volume":"4","author":"Stock","year":"2013","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.brainresrev.2004.12.006","article-title":"Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK\/STAT\/SOCS signaling circuits in the CNS","volume":"48","author":"Campbell","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J Autoimmun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.4049\/jimmunol.181.5.3167","article-title":"Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes","volume":"181","author":"Qin","year":"2008","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.4049\/jimmunol.166.4.2260","article-title":"IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein","volume":"166","author":"O\u2019Keefe","year":"2001","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.4049\/jimmunol.169.5.2354","article-title":"Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages","volume":"169","author":"Wesemann","year":"2002","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2169\/internalmedicine.52.9458","article-title":"Liver dysfunction in patients with systemic lupus erythematosus","volume":"52","author":"Takahashi","year":"2013","journal-title":"Intern Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3899\/jrheum.080336","article-title":"Liver involvement in systemic lupus erythematosus: case review of 40 patients","volume":"35","author":"Chowdhary","year":"2008","journal-title":"J Rheumatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/art.20869","article-title":"Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes","volume":"52","author":"Nagai","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B95","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","article-title":"T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile","volume":"41","author":"Longhi","year":"2013","journal-title":"J Autoimmun"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20031675","article-title":"SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis","volume":"199","author":"Yoshida","year":"2004","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00005-015-0356-8","article-title":"The role of CXC chemokines in pulmonary fibrosis of systemic lupus erythematosus patients","volume":"63","author":"Nielepkowicz-Go\u017adzi\u0144ska","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.20452\/pamw.1676","article-title":"Exhaled cytokines in systemic lupus erythematosus with lung involvement","volume":"123","author":"Nielepkowicz-Go\u017adzi\u0144ska","year":"2013","journal-title":"Pol Arch Med Wewn"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.bbrc.2006.12.128","article-title":"Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis","volume":"353","author":"Shoda","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jaci.2008.02.003","article-title":"Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis","volume":"121","author":"Nakashima","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.4049\/jimmunol.172.12.7510","article-title":"Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function","volume":"172","author":"Flowers","year":"2004","journal-title":"J Immunol"},{"key":"B102","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.4049\/jimmunol.175.8.5077","article-title":"Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing\/remitting form","volume":"175","author":"Mujtaba","year":"2005","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01292\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T10:09:30Z","timestamp":1750932570000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01292\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":102,"alternative-id":["10.3389\/fimmu.2017.01292"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01292","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]},"article-number":"1292"}}